Use of Autologous Serum Eye Drops with Contact Lenses in the Treatment of Chemical Burn-Induced Bilateral Corneal Persistent Epithelial Defects

Biomed Res Int. 2022 Feb 21:2022:6600788. doi: 10.1155/2022/6600788. eCollection 2022.

Abstract

Objective: We aim to evaluate the clinical effect of combined topical 20% autologous serum eye drops (ASEs) along with silicone-hydrogel soft contact lenses (SCLs) in the treatment of chemical burn-induced bilateral corneal persistent epithelial defects (PEDs) and to review the literature of related studies.

Methods: From January 1, 2017, to December 31, 2019, we conducted a retrospective chart review of 8 patients with chemical burn-induced bilateral corneal PEDs who were unsuccessfully treated with conventional medical therapy and were then treated with combined topical 20% (v/v) ASEs and silicone-hydrogel CLs. The clinical effects and effectiveness of the combined treatment were evaluated.

Results: The bilateral corneal PEDs healed in all sixteen eyes of the eight patients within 2 weeks. The patients did not report any discomfort associated with the combined treatment. Improved ocular comfort/visual acuity and decreased conjunctival injection correlated with healing. No recurrent corneal epithelial breakdown was noted during the 3-month posttreatment follow-up.

Conclusions: The combined treatment of silicone-hydrogel CLs and ASEs can help to stabilize the ocular surface and successfully treat chemical burn-induced bilateral corneal PEDs. It may be considered as an alternative treatment method for patients with bilateral chemical burn-induced corneal PEDs with potential corneal melting.

Publication types

  • Review

MeSH terms

  • Adult
  • Burns, Chemical / complications*
  • Burns, Chemical / drug therapy
  • Corneal Diseases / etiology
  • Corneal Diseases / therapy*
  • Epithelium, Corneal / drug effects
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions / therapeutic use*
  • Transplantation, Autologous
  • Treatment Outcome
  • Wound Healing / drug effects*

Substances

  • Ophthalmic Solutions